APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acyclovir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Acyclovir Market Analysis and Forecast 2026-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchAcyclovir Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Acyclovir Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Acyclovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acyclovir Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Acyclovir Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Acyclovir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Acyclovir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Acyclovir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Acyclovir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Acyclovir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Acyclovir include GSK, TEVA, Mylan, Fresenius Kabi, Zydus Pharmaceuticals, Vectans Pharma (Onxeo), Bausch Health and APOTEX, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Acyclovir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Acyclovir, also provides the sales of main regions and countries. Of the upcoming market potential for Acyclovir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acyclovir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Acyclovir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Acyclovir sales, projected growth trends, production technology, application and end-user industry.

Acyclovir Segment by Company

GSK

TEVA

Mylan

Fresenius Kabi

Zydus Pharmaceuticals

Vectans Pharma (Onxeo)

Bausch Health

APOTEX

Acyclovir Segment by Type

Oral Product

Injection Product

Acyclovir Segment by Application

Hospitals

Clinics

Others

Acyclovir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acyclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acyclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acyclovir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Acyclovir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Acyclovir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acyclovir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acyclovir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Product Major Manufacturers Table 3. Injection Product Major Manufacturers Table 4. Global Acyclovir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. Acyclovir Industry Trends Table 9. Acyclovir Industry Drivers Table 10. Acyclovir Industry Opportunities and Challenges Table 11. Acyclovir Industry Restraints Table 12. Global Acyclovir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Acyclovir Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Acyclovir Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Acyclovir Revenue Market Share by Region (2021-2026) Table 16. Global Acyclovir Revenue Market Share by Region (2027-2032) Table 17. Global Acyclovir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Acyclovir Sales by Region (2021-2026) & (K Units) Table 19. Global Acyclovir Sales by Region (2027-2032) & (K Units) Table 20. Global Acyclovir Sales Market Share by Region (2021-2026) Table 21. Global Acyclovir Sales Market Share by Region (2027-2032) Table 22. Global Acyclovir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Acyclovir Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Acyclovir Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Acyclovir Sales Market Share by Manufacturers (2021-2026) Table 26. Global Acyclovir Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Acyclovir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Acyclovir Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Acyclovir Manufacturers, Product Type & Application Table 30. Global Acyclovir Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Acyclovir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Acyclovir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Acyclovir Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Acyclovir Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Acyclovir Revenue Market Share by Type (2021-2026) Table 37. Global Acyclovir Revenue Market Share by Type (2027-2032) Table 38. Global Acyclovir Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Acyclovir Sales by Type (2021-2026) & (K Units) Table 40. Global Acyclovir Sales by Type (2027-2032) & (K Units) Table 41. Global Acyclovir Sales Market Share by Type (2021-2026) Table 42. Global Acyclovir Sales Market Share by Type (2027-2032) Table 43. Global Acyclovir Price by Type (2021-2026) & (US$/Unit) Table 44. Global Acyclovir Price by Type (2027-2032) & (US$/Unit) Table 45. Global Acyclovir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Acyclovir Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Acyclovir Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Acyclovir Revenue Market Share by Application (2021-2026) Table 49. Global Acyclovir Revenue Market Share by Application (2027-2032) Table 50. Global Acyclovir Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Acyclovir Sales by Application (2021-2026) & (K Units) Table 52. Global Acyclovir Sales by Application (2027-2032) & (K Units) Table 53. Global Acyclovir Sales Market Share by Application (2021-2026) Table 54. Global Acyclovir Sales Market Share by Application (2027-2032) Table 55. Global Acyclovir Price by Application (2021-2026) & (US$/Unit) Table 56. Global Acyclovir Price by Application (2027-2032) & (US$/Unit) Table 57. GSK Company Information Table 58. GSK Business Overview Table 59. GSK Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. GSK Acyclovir Product Portfolio Table 61. GSK Recent Development Table 62. TEVA Company Information Table 63. TEVA Business Overview Table 64. TEVA Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. TEVA Acyclovir Product Portfolio Table 66. TEVA Recent Development Table 67. Mylan Company Information Table 68. Mylan Business Overview Table 69. Mylan Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Mylan Acyclovir Product Portfolio Table 71. Mylan Recent Development Table 72. Fresenius Kabi Company Information Table 73. Fresenius Kabi Business Overview Table 74. Fresenius Kabi Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Fresenius Kabi Acyclovir Product Portfolio Table 76. Fresenius Kabi Recent Development Table 77. Zydus Pharmaceuticals Company Information Table 78. Zydus Pharmaceuticals Business Overview Table 79. Zydus Pharmaceuticals Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Zydus Pharmaceuticals Acyclovir Product Portfolio Table 81. Zydus Pharmaceuticals Recent Development Table 82. Vectans Pharma (Onxeo) Company Information Table 83. Vectans Pharma (Onxeo) Business Overview Table 84. Vectans Pharma (Onxeo) Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Vectans Pharma (Onxeo) Acyclovir Product Portfolio Table 86. Vectans Pharma (Onxeo) Recent Development Table 87. Bausch Health Company Information Table 88. Bausch Health Business Overview Table 89. Bausch Health Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bausch Health Acyclovir Product Portfolio Table 91. Bausch Health Recent Development Table 92. APOTEX Company Information Table 93. APOTEX Business Overview Table 94. APOTEX Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. APOTEX Acyclovir Product Portfolio Table 96. APOTEX Recent Development Table 97. North America Acyclovir Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Acyclovir Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Acyclovir Sales by Type (2021-2026) & (K Units) Table 100. North America Acyclovir Sales by Type (2027-2032) & (K Units) Table 101. North America Acyclovir Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America Acyclovir Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America Acyclovir Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Acyclovir Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Acyclovir Sales by Application (2021-2026) & (K Units) Table 106. North America Acyclovir Sales by Application (2027-2032) & (K Units) Table 107. North America Acyclovir Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America Acyclovir Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Acyclovir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Acyclovir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Acyclovir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. North America Acyclovir Sales by Country (2021-2026) & (K Units) Table 114. North America Acyclovir Sales by Country (2027-2032) & (K Units) Table 115. North America Acyclovir Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America Acyclovir Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States Acyclovir Revenue (2021-2032) & (US$ Million) Table 118. Canada Acyclovir Revenue (2021-2032) & (US$ Million) Table 119. Europe Acyclovir Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Acyclovir Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Acyclovir Sales by Type (2021-2026) & (K Units) Table 122. Europe Acyclovir Sales by Type (2027-2032) & (K Units) Table 123. Europe Acyclovir Sales Price by Type (2021-2026) & (US$/Unit) Table 124. Europe Acyclovir Sales Price by Type (2027-2032) & (US$/Unit) Table 125. Europe Acyclovir Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Acyclovir Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Acyclovir Sales by Application (2021-2026) & (K Units) Table 128. Europe Acyclovir Sales by Application (2027-2032) & (K Units) Table 129. Europe Acyclovir Sales Price by Application (2021-2026) & (US$/Unit) Table 130. Europe Acyclovir Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Europe Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Acyclovir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Acyclovir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Acyclovir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 135. Europe Acyclovir Sales by Country (2021-2026) & (K Units) Table 136. Europe Acyclovir Sales by Country (2027-2032) & (K Units) Table 137. Europe Acyclovir Sales Price by Country (2021-2026) & (US$/Unit) Table 138. Europe Acyclovir Sales Price by Country (2027-2032) & (US$/Unit) Table 139. Germany Acyclovir Revenue (2021-2032) & (US$ Million) Table 140. France Acyclovir Revenue (2021-2032) & (US$ Million) Table 141. U.K. Acyclovir Revenue (2021-2032) & (US$ Million) Table 142. Italy Acyclovir Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Acyclovir Revenue (2021-2032) & (US$ Million) Table 144. China Acyclovir Revenue by Type (2021-2026) & (US$ Million) Table 145. China Acyclovir Revenue by Type (2027-2032) & (US$ Million) Table 146. China Acyclovir Sales by Type (2021-2026) & (K Units) Table 147. China Acyclovir Sales by Type (2027-2032) & (K Units) Table 148. China Acyclovir Sales Price by Type (2021-2026) & (US$/Unit) Table 149. China Acyclovir Sales Price by Type (2027-2032) & (US$/Unit) Table 150. China Acyclovir Revenue by Application (2021-2026) & (US$ Million) Table 151. China Acyclovir Revenue by Application (2027-2032) & (US$ Million) Table 152. China Acyclovir Sales by Application (2021-2026) & (K Units) Table 153. China Acyclovir Sales by Application (2027-2032) & (K Units) Table 154. China Acyclovir Sales Price by Application (2021-2026) & (US$/Unit) Table 155. China Acyclovir Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Acyclovir Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Acyclovir Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Acyclovir Sales by Type (2021-2026) & (K Units) Table 159. Asia Acyclovir Sales by Type (2027-2032) & (K Units) Table 160. Asia Acyclovir Sales Price by Type (2021-2026) & (US$/Unit) Table 161. Asia Acyclovir Sales Price by Type (2027-2032) & (US$/Unit) Table 162. Asia Acyclovir Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Acyclovir Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Acyclovir Sales by Application (2021-2026) & (K Units) Table 165. Asia Acyclovir Sales by Application (2027-2032) & (K Units) Table 166. Asia Acyclovir Sales Price by Application (2021-2026) & (US$/Unit) Table 167. Asia Acyclovir Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Acyclovir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Acyclovir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Acyclovir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. Asia Acyclovir Sales by Country (2021-2026) & (K Units) Table 173. Asia Acyclovir Sales by Country (2027-2032) & (K Units) Table 174. Asia Acyclovir Sales Price by Country (2021-2026) & (US$/Unit) Table 175. Asia Acyclovir Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Japan Acyclovir Revenue (2021-2032) & (US$ Million) Table 177. South Korea Acyclovir Revenue (2021-2032) & (US$ Million) Table 178. India Acyclovir Revenue (2021-2032) & (US$ Million) Table 179. Australia Acyclovir Revenue (2021-2032) & (US$ Million) Table 180. China Taiwan Acyclovir Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Acyclovir Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Acyclovir Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Acyclovir Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Acyclovir Sales by Type (2021-2026) & (K Units) Table 185. SAMEA Acyclovir Sales by Type (2027-2032) & (K Units) Table 186. SAMEA Acyclovir Sales Price by Type (2021-2026) & (US$/Unit) Table 187. SAMEA Acyclovir Sales Price by Type (2027-2032) & (US$/Unit) Table 188. SAMEA Acyclovir Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Acyclovir Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Acyclovir Sales by Application (2021-2026) & (K Units) Table 191. SAMEA Acyclovir Sales by Application (2027-2032) & (K Units) Table 192. SAMEA Acyclovir Sales Price by Application (2021-2026) & (US$/Unit) Table 193. SAMEA Acyclovir Sales Price by Application (2027-2032) & (US$/Unit) Table 194. SAMEA Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Acyclovir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Acyclovir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Acyclovir Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. SAMEA Acyclovir Sales by Country (2021-2026) & (K Units) Table 199. SAMEA Acyclovir Sales by Country (2027-2032) & (K Units) Table 200. SAMEA Acyclovir Sales Price by Country (2021-2026) & (US$/Unit) Table 201. SAMEA Acyclovir Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Brazil Acyclovir Revenue (2021-2032) & (US$ Million) Table 203. Argentina Acyclovir Revenue (2021-2032) & (US$ Million) Table 204. Chile Acyclovir Revenue (2021-2032) & (US$ Million) Table 205. Colombia Acyclovir Revenue (2021-2032) & (US$ Million) Table 206. Peru Acyclovir Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Acyclovir Revenue (2021-2032) & (US$ Million) Table 208. Israel Acyclovir Revenue (2021-2032) & (US$ Million) Table 209. UAE Acyclovir Revenue (2021-2032) & (US$ Million) Table 210. Turkey Acyclovir Revenue (2021-2032) & (US$ Million) Table 211. Iran Acyclovir Revenue (2021-2032) & (US$ Million) Table 212. Egypt Acyclovir Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Acyclovir Distributors List Table 216. Acyclovir Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Acyclovir Image Figure 2. Global Acyclovir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acyclovir Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Product Image Figure 5. Injection Product Image Figure 6. Global Acyclovir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Acyclovir Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global Acyclovir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Acyclovir Revenue (2021-2032) & (US$ Million) Figure 13. Global Acyclovir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Acyclovir Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Acyclovir Revenue Market Share by Region (2021-2032) Figure 16. Global Acyclovir Sales (2021-2032) & (K Units) Figure 17. Global Acyclovir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Acyclovir Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Acyclovir Sales YoY (2021-2032) & (K Units) Figure 20. Europe Acyclovir Sales YoY (2021-2032) & (K Units) Figure 21. China Acyclovir Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Acyclovir Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Acyclovir Sales YoY (2021-2032) & (K Units) Figure 24. Global Acyclovir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Acyclovir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Acyclovir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Acyclovir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Acyclovir Revenue Market Share by Type (2021-2032) Figure 30. Global Acyclovir Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Acyclovir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Acyclovir Sales Market Share by Type (2021-2032) Figure 33. Global Acyclovir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Acyclovir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Acyclovir Revenue Market Share by Application (2021-2032) Figure 36. Global Acyclovir Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Acyclovir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Acyclovir Sales Market Share by Application (2021-2032) Figure 39. North America Acyclovir Revenue Share by Type (2021-2032) Figure 40. North America Acyclovir Sales Share by Type (2021-2032) Figure 41. North America Acyclovir Revenue Share by Application (2021-2032) Figure 42. North America Acyclovir Sales Share by Application (2021-2032) Figure 43. North America Acyclovir Revenue Share by Country (2021-2032) Figure 44. North America Acyclovir Sales Share by Country (2021-2032) Figure 45. Europe Acyclovir Revenue Share by Type (2021-2032) Figure 46. Europe Acyclovir Sales Share by Type (2021-2032) Figure 47. Europe Acyclovir Revenue Share by Application (2021-2032) Figure 48. Europe Acyclovir Sales Share by Application (2021-2032) Figure 49. Europe Acyclovir Revenue Share by Country (2021-2032) Figure 50. Europe Acyclovir Sales Share by Country (2021-2032) Figure 51. China Acyclovir Revenue Share by Type (2021-2032) Figure 52. China Acyclovir Sales Share by Type (2021-2032) Figure 53. China Acyclovir Revenue Share by Application (2021-2032) Figure 54. China Acyclovir Sales Share by Application (2021-2032) Figure 55. Asia Acyclovir Revenue Share by Type (2021-2032) Figure 56. Asia Acyclovir Sales Share by Type (2021-2032) Figure 57. Asia Acyclovir Revenue Share by Application (2021-2032) Figure 58. Asia Acyclovir Sales Share by Application (2021-2032) Figure 59. Asia Acyclovir Revenue Share by Country (2021-2032) Figure 60. Asia Acyclovir Sales Share by Country (2021-2032) Figure 61. SAMEA Acyclovir Revenue Share by Type (2021-2032) Figure 62. SAMEA Acyclovir Sales Share by Type (2021-2032) Figure 63. SAMEA Acyclovir Revenue Share by Application (2021-2032) Figure 64. SAMEA Acyclovir Sales Share by Application (2021-2032) Figure 65. SAMEA Acyclovir Revenue Share by Country (2021-2032) Figure 66. SAMEA Acyclovir Sales Share by Country (2021-2032) Figure 67. Acyclovir Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Acyclovir Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Product
  • Injection Product
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • GSK
  • TEVA
  • Mylan
  • Fresenius Kabi
  • Zydus Pharmaceuticals
  • Vectans Pharma (Onxeo)
  • Bausch Health
  • APOTEX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Acyclovir Market by Type
  3. 1.2.1 Global Acyclovir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Product
  5. 1.2.3 Injection Product
  6. 1.3 Acyclovir Market by Application
  7. 1.3.1 Global Acyclovir Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Acyclovir Market Dynamics
  1. 2.1 Acyclovir Industry Trends
  2. 2.2 Acyclovir Industry Drivers
  3. 2.3 Acyclovir Industry Opportunities and Challenges
  4. 2.4 Acyclovir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Acyclovir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Acyclovir Revenue by Region
  3. 3.2.1 Global Acyclovir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Acyclovir Revenue by Region (2021-2026)
  5. 3.2.3 Global Acyclovir Revenue by Region (2027-2032)
  6. 3.2.4 Global Acyclovir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Acyclovir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Acyclovir Sales by Region
  9. 3.4.1 Global Acyclovir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Acyclovir Sales by Region (2021-2026)
  11. 3.4.3 Global Acyclovir Sales by Region (2027-2032)
  12. 3.4.4 Global Acyclovir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Acyclovir Revenue by Manufacturers
  2. 4.1.1 Global Acyclovir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Acyclovir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Acyclovir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Acyclovir Sales by Manufacturers
  6. 4.2.1 Global Acyclovir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Acyclovir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Acyclovir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Acyclovir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Acyclovir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Acyclovir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Acyclovir Manufacturers, Product Type & Application
  13. 4.7 Global Acyclovir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Acyclovir Market CR5 and HHI
  16. 4.8.2 2025 Acyclovir Tier 1, Tier 2, and Tier 3
5 Acyclovir Market by Type
  1. 5.1 Global Acyclovir Revenue by Type
  2. 5.1.1 Global Acyclovir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Acyclovir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Acyclovir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Acyclovir Sales by Type
  6. 5.2.1 Global Acyclovir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Acyclovir Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Acyclovir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Acyclovir Price by Type
6 Acyclovir Market by Application
  1. 6.1 Global Acyclovir Revenue by Application
  2. 6.1.1 Global Acyclovir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Acyclovir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Acyclovir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Acyclovir Sales by Application
  6. 6.2.1 Global Acyclovir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Acyclovir Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Acyclovir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Acyclovir Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Acyclovir Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 TEVA
  8. 7.2.1 TEVA Company Information
  9. 7.2.2 TEVA Business Overview
  10. 7.2.3 TEVA Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 TEVA Acyclovir Product Portfolio
  12. 7.2.5 TEVA Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Acyclovir Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Fresenius Kabi
  20. 7.4.1 Fresenius Kabi Company Information
  21. 7.4.2 Fresenius Kabi Business Overview
  22. 7.4.3 Fresenius Kabi Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fresenius Kabi Acyclovir Product Portfolio
  24. 7.4.5 Fresenius Kabi Recent Developments
  25. 7.5 Zydus Pharmaceuticals
  26. 7.5.1 Zydus Pharmaceuticals Company Information
  27. 7.5.2 Zydus Pharmaceuticals Business Overview
  28. 7.5.3 Zydus Pharmaceuticals Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zydus Pharmaceuticals Acyclovir Product Portfolio
  30. 7.5.5 Zydus Pharmaceuticals Recent Developments
  31. 7.6 Vectans Pharma (Onxeo)
  32. 7.6.1 Vectans Pharma (Onxeo) Company Information
  33. 7.6.2 Vectans Pharma (Onxeo) Business Overview
  34. 7.6.3 Vectans Pharma (Onxeo) Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Vectans Pharma (Onxeo) Acyclovir Product Portfolio
  36. 7.6.5 Vectans Pharma (Onxeo) Recent Developments
  37. 7.7 Bausch Health
  38. 7.7.1 Bausch Health Company Information
  39. 7.7.2 Bausch Health Business Overview
  40. 7.7.3 Bausch Health Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bausch Health Acyclovir Product Portfolio
  42. 7.7.5 Bausch Health Recent Developments
  43. 7.8 APOTEX
  44. 7.8.1 APOTEX Company Information
  45. 7.8.2 APOTEX Business Overview
  46. 7.8.3 APOTEX Acyclovir Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 APOTEX Acyclovir Product Portfolio
  48. 7.8.5 APOTEX Recent Developments
8 North America
  1. 8.1 North America Acyclovir Market Size by Type
  2. 8.1.1 North America Acyclovir Revenue by Type (2021-2032)
  3. 8.1.2 North America Acyclovir Sales by Type (2021-2032)
  4. 8.1.3 North America Acyclovir Price by Type (2021-2032)
  5. 8.2 North America Acyclovir Market Size by Application
  6. 8.2.1 North America Acyclovir Revenue by Application (2021-2032)
  7. 8.2.2 North America Acyclovir Sales by Application (2021-2032)
  8. 8.2.3 North America Acyclovir Price by Application (2021-2032)
  9. 8.3 North America Acyclovir Market Size by Country
  10. 8.3.1 North America Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Acyclovir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Acyclovir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Acyclovir Market Size by Type
  2. 9.1.1 Europe Acyclovir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Acyclovir Sales by Type (2021-2032)
  4. 9.1.3 Europe Acyclovir Price by Type (2021-2032)
  5. 9.2 Europe Acyclovir Market Size by Application
  6. 9.2.1 Europe Acyclovir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Acyclovir Sales by Application (2021-2032)
  8. 9.2.3 Europe Acyclovir Price by Application (2021-2032)
  9. 9.3 Europe Acyclovir Market Size by Country
  10. 9.3.1 Europe Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Acyclovir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Acyclovir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Acyclovir Market Size by Type
  2. 10.1.1 China Acyclovir Revenue by Type (2021-2032)
  3. 10.1.2 China Acyclovir Sales by Type (2021-2032)
  4. 10.1.3 China Acyclovir Price by Type (2021-2032)
  5. 10.2 China Acyclovir Market Size by Application
  6. 10.2.1 China Acyclovir Revenue by Application (2021-2032)
  7. 10.2.2 China Acyclovir Sales by Application (2021-2032)
  8. 10.2.3 China Acyclovir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Acyclovir Market Size by Type
  2. 11.1.1 Asia Acyclovir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Acyclovir Sales by Type (2021-2032)
  4. 11.1.3 Asia Acyclovir Price by Type (2021-2032)
  5. 11.2 Asia Acyclovir Market Size by Application
  6. 11.2.1 Asia Acyclovir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Acyclovir Sales by Application (2021-2032)
  8. 11.2.3 Asia Acyclovir Price by Application (2021-2032)
  9. 11.3 Asia Acyclovir Market Size by Country
  10. 11.3.1 Asia Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Acyclovir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Acyclovir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Acyclovir Market Size by Type
  2. 12.1.1 SAMEA Acyclovir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Acyclovir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Acyclovir Price by Type (2021-2032)
  5. 12.2 SAMEA Acyclovir Market Size by Application
  6. 12.2.1 SAMEA Acyclovir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Acyclovir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Acyclovir Price by Application (2021-2032)
  9. 12.3 SAMEA Acyclovir Market Size by Country
  10. 12.3.1 SAMEA Acyclovir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Acyclovir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Acyclovir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Acyclovir Value Chain Analysis
  2. 13.1.1 Acyclovir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Acyclovir Production Mode & Process
  6. 13.2 Acyclovir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Acyclovir Distributors
  9. 13.2.3 Acyclovir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst